David H. Raulet
1979–2026 年に発表
- 125
- 論文数
- 36,767
- 被引用数
- 97
- h 指数
- 123
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Immunology and Microbiology59.1%
- Medicine26%
- Biochemistry, Genetics and Molecular Biology11.1%
- Neuroscience1.3%
- Engineering0.9%
- Mathematics0.4%
- その他1.2%
トピック
- Immune Cell Function and Interaction18.8%
- T-cell and B-cell Immunology12%
- Immunotherapy and Immune Responses6.5%
- CAR-T cell therapy research5.5%
- Cancer Immunotherapy and Biomarkers3.8%
- Immune cells in cancer3%
- その他50.4%
共著者
- A. M. Jamieson11
- Andreas Diefenbach10
- Russell E. Vance10
- Mark Bix8
- Stephan Gasser8
- Alexandre Iannello7
- Christopher W. McMahon7
- Dragana Cado7
- Mark Coles7
- Michele Ardolino7
- Werner Held7
- Na Xiong6
- Natalie K. Wolf6
- Jeffrey R. Dorfman5
- Maarten Zijlstra5
- Nan‐Shih Liao5
- Rudolf Jaenisch5
- Thornton W. Thompson5
- Éric Vivier5
- Assaf Marcus4
- Benjamin G. Gowen4
- Christopher J. Nicolai4
- Isabel Corrêa4
- James R. Carlyle4
全論文
- Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
著者: Natalie K. Wolf, Djem Kissiov, David H. Raulet - Nature reviews. Immunology 2022 被引用: 545
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
著者: Éric Vivier, David H. Raulet, Alessandro Moretta, Michael A. Caligiuri, Laurence Zitvogel, Lewis L. Lanier, Wayne M. Yokoyama, Sophie Ugolini - Science 2011 被引用: 2,757
- Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
著者: Assaf Marcus, Amy J. Mao, Monisha Lensink-Vasan, LeeAnn Wang, Russell E. Vance, David H. Raulet - Immunity 2018 被引用: 612
- Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
著者: Joy Hsu, Jonathan J. Hodgins, Malvika Marathe, Chris J. Nicolai, Marie‐Claude Bourgeois‐Daigneault, Troy N. Trevino, Camillia S. Azimi, Amit Scheer, Haley E. Randolph, Thornton W. Thompson, Lily Zhang, Alexandre Iannello, Nikhita Mathur, Karen Jardine, Georgia Kirn, John C. Bell, Michael W. McBurney, David H. Raulet, Michele Ardolino - Journal of Clinical Investigation 2018 被引用: 827
- NK cells mediate clearance of CD8 + T cell–resistant tumors in response to STING agonists
著者: Christopher J. Nicolai, Natalie K. Wolf, I-Chang Chang, Georgia Kirn, Assaf Marcus, Chudi Ndubaku, Sarah M. McWhirter, David H. Raulet - Science Immunology 2020 被引用: 266
- SLC19A1 transports immunoreactive cyclic dinucleotides
著者: Rutger D. Luteijn, Shivam A. Zaver, Benjamin G. Gowen, Stacia K. Wyman, Nick E. Garelis, Liberty Onia, Sarah M. McWhirter, George E. Katibah, Jacob E. Corn, Joshua J. Woodward, David H. Raulet - Nature 2019 被引用: 385
- Neutrophils Suppress Intraluminal NK Cell–Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells
著者: Asaf Spiegel, Mary W. Brooks, Samin Houshyar, Ferenc Reinhardt, Michele Ardolino, Evelyn Fessler, Michelle B. Chen, Jordan A. Krall, Jasmine DeCock, Ioannis K. Zervantonakis, Alexandre Iannello, Yoshiko Iwamoto, Virna Cortez‐Retamozo, Roger D. Kamm, Mikaël J. Pittet, David H. Raulet, Robert A. Weinberg - Cancer Discovery 2016 被引用: 466
- Regulation of Ligands for the NKG2D Activating Receptor
著者: David H. Raulet, Stephan Gasser, Benjamin G. Gowen, Weiwen Deng, Heiyoun Jung - Annual Review of Immunology 2013 被引用: 821
- p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells
著者: Alexandre Iannello, Thornton W. Thompson, Michele Ardolino, Scott W. Lowe, David H. Raulet - The Journal of Experimental Medicine 2013 被引用: 401
- Innate immune cells in the tumor microenvironment
著者: Ming O. Li, Natalie K. Wolf, David H. Raulet, Leila Akkari, Mikaël J. Pittet, Paulo C. Rodrı́guez, Rosandra N. Kaplan, Ariel Munitz, Zemin Zhang, Sijin Cheng, Nina Bhardwaj - Cancer Cell 2021 被引用: 136
- Roles of the NKG2D immunoreceptor and its ligands
著者: David H. Raulet - Nature reviews. Immunology 2003 被引用: 1,332
- The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
著者: Stephan Gasser, Sandra Oršulić, Eric J. Brown, David H. Raulet - Nature 2005 被引用: 1,278
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy
著者: Nadia Guerra, Ying Xim Tan, Nathalie T. Joncker, Augustine Choy, Fermin Gallardo, Na Xiong, Susan Knoblaugh, Dragana Cado, Norman R. Greenberg, David H. Raulet - Immunity 2008 被引用: 813
- Coordinated Induction by IL15 of a TCR-Independent NKG2D Signaling Pathway Converts CTL into Lymphokine-Activated Killer Cells in Celiac Disease
著者: Bertrand Meresse, Zhangguo Chen, Cezary Ciszewski, Maria Tretiakova, Govind Bhagat, Thomas Krausz, David H. Raulet, Lewis L. Lanier, Veronika Groh, Thomas A. Spies, Ellen C. Ebert, Peter H. Green, Bana Jabrì - Immunity 2004 被引用: 833
- Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging
著者: Denise P. Muñoz, Steven M. Yannone, Anneleen Daemen, Yu Sun, Funda Vakar‐Lopez, Misako Kawahara, Adam Freund, Françis Rodier, Jennifer D. Wu, Pierre-Yves Desprez, David H. Raulet, Peter S. Nelson, Laura van ‘t Veer, Judith Campisi, Jean-Philippe Coppé - JCI Insight 2019 被引用: 154
- Self-tolerance of natural killer cells
著者: David H. Raulet, Russell E. Vance - Nature reviews. Immunology 2006 被引用: 577
- RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
著者: Adeline R. Lam, Nina Le Bert, Samantha S.W. Ho, Yu J. Shen, Melissa L.F. Tang, Gordon M. Xiong, J. Ludovic Croxford, Christine X. Koo, Ken J. Ishii, Shizuo Akira, David H. Raulet, Stephan Gasser - Cancer Research 2014 被引用: 175
- Tumor-induced disruption of the blood-brain barrier promotes host death
著者: Jung Kim, Hsiu‐Chun Chuang, Natalie K. Wolf, Christopher J. Nicolai, David H. Raulet, Kaoru Saijo, David Bilder - Developmental Cell 2021 被引用: 76
- Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
著者: Andreas Diefenbach, Eric R. Jensen, A. M. Jamieson, David H. Raulet - Nature 2001 被引用: 1,065
- The Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural Killing
著者: A. M. Jamieson, Andreas Diefenbach, Christopher W. McMahon, Na Xiong, James R. Carlyle, David H. Raulet - Immunity 2002 被引用: 629
- Cytokine therapy reverses NK cell anergy in MHC-deficient tumors
著者: Michele Ardolino, Camillia S. Azimi, Alexandre Iannello, Troy N. Trevino, Lucas H. Horan, Lily Zhang, Weiwen Deng, Aaron M. Ring, Suzanne Fischer, K. Christopher García, David H. Raulet - Journal of Clinical Investigation 2014 被引用: 192
- MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity
著者: Nan‐Shih Liao, Mark Bix, Maarten Zijlstra, Rudolf Jaenisch, David H. Raulet - Science 1991 被引用: 479
- Recognition of Tumors by the Innate Immune System and Natural Killer Cells
著者: Assaf Marcus, Benjamin G. Gowen, Thornton W. Thompson, Alexandre Iannello, Michele Ardolino, Weiwen Deng, Lin Wang, Nataliya Tovbis Shifrin, David H. Raulet - Advances in immunology 2014 被引用: 364
- Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice
著者: Mark Bix, Nan‐Shih Liao, Maarten Zijlstra, Janet M. Loring, Rudolf Jaenisch, David H. Raulet - Nature 1991 被引用: 424
